Company Background

Bioniche Animal Health Bioniche Life Sciences Inc. is a leading Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide. Bioniche employs more then 300 people and has three principal reporting divisions: Human Health, Animal Health, and Food Safety. Corporate headquarters are located in Belleville, Ontario, Canada, with research, manufacturing, and marketing/sales facilities in Belleville, as well as in Armidale, Australia; Athens, Georgia; Galway, Ireland; Geneva, Switzerland; Montreal, Quebec; and Pullman, Washington.

For more information visit www.bioniche.com.

Bioniche Life Sciences Inc. trades on the Toronto Stock Exchange (TSX) under the symbol "BNC".

Bioniche Animal Health was formed in 1979 as a privately owned company to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. Bioniche Animal Health has its own manufacturing facility in Belleville, Ontario, in house laboratories, and 100 acre research farm. The company has established close liaisons with a number of Canadian universities active in medical and veterinary research.

Nature of the Business

Bioniche Animal Health produces a wide range of animal vaccines, as well as a patented immune stimulant, for use in cattle, swine, equine and companion animals. The company also markets a number of other veterinary pharmaceutical products, such as anti-inflammatory agents, reproductive hormones, and nutritional supplements.

Major Achievements

Developed a purified follicle stimulating hormone that initiates superovulation.
Developed a patented immunostimulant for the treatment of equine respiratory disease, neonatal calf diarrhea, and tumours in companion animals.
Developed methods for the production of polyclonal antibodies.
Patented use of hyaluronic acid for the cryopreservation of embryos and tissues of animal and man.

Key Developments

2002 - Vetrepharm becomes BIONICHE Animal Health on July 1, 2002.
1999 - The company merged animal and human health activities under Bioniche Life Sciences Inc. for public trading on the Toronto Stock Exchange under the stock symbol BNC.
1995 - Ireland office is opened.
1992 - Vetrepharm expanded into the human health territory through the incorporation of Bioniche.
1990 - Australian office opens.
1980 - USA office opens in Athens, Georgia.
1979 - Vetrepharm incorporated London, Ontario.